Lys-MDMA | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Physical properties [] | |
---|---|
Molecular mass | 321.4 g/mol [1] |
Predicted LogP | 1.2 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C17H27N3O3 [1] |
IUPAC name | (2S)-2,6-diamino-N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]-N-methylhexanamide [1] |
SMILES | CC(CC1=CC2=C(C=C1)OCO2)N(C)C(=O)[C@H](CCCCN)N [1] |
InChI | InChI=1S/C17H27N3O3/c1-12(20(2)17(21)14(19)5-3-4-8-18)9-13-6-7-15-16(10-13)23-11-22-15/h6-7,10,12,14H,3-5,8-9,11,18-19H2,1-2H3/t12?,14-/m0/s1 [1] |
InChIKey | MJBFXZNNDCEDME-PYMCNQPYSA-N [1] |
N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine
N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine is a codrug, prodrug, entactogen and stimulant substance of the methylenedioxyphenethylamine class.
Chemistry
Stereochemistry []
N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine is a racemic mixture of the enantiomers
Stereoisomers |
---|
Pharmacology
N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine acts as a codrug for:
Active metabolites [] |
---|
Subjective effects
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 166468301, N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine. Accessed July 28, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/166468301